SINGLE-PHASE PHARMACEUTICAL COMPOSITE PREPARATION (DIENOGESTAND ETHINYL ESTRADIOL) FOR ORAL THERAPY FOR REGULATION OF BLOOD PRESSURE

摘要

The invention relates to single-phase oral contraceptives comprising a co mbination of 2.0 mg dienogest of the non-aldosterone antagonist type and 0.0 30 mg ethinyl estradiol or 2.0 mg dienogest and 0.020 mg ethinyl estradiol o r 2.0 mg dienogest and 0.015 mg ethinyl estradiol or 1.5 mg dienogest and 0. 015 mg ethinyl estradiol in at least (21) daily dosage units. Said oral cont raceptives achieve a regulation of blood pressure - reducing elevated blood pressure and increasing depressed blood pressure - during contraception. Sai d oral contraceptives are particularly suitable for long-term contraceptive use without the risk of negative influence on blood pressure.